Notice of Application to Register a Trade Name Product (Notice No. MPI 1044)
Shaleen Narayan, Acting Manager Approvals Operations, of the Ministry for Primary Industries (“MPI”), acting under delegated authority from the Director-General of MPI, gives notice under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 (“Act”) that the following application has been made to register a trade name product under section 9(1) of the Act:
Trade Name: Semintra 10mg/mL Oral Solution for Cats
Reference: A011739
Active Ingredient and Concentration:
Telmisartan 10mg/mL
Formulation Type: Aqueous Solution
General Use Claim:
For the treatment of systemic hypertension in cats. For the reduction of proteinuria in cats with chronic kidney disease.
Any person may make a written submission to the director-general concerning this application.
Under sections 16 and 17 of the Act, a written submission:
Under section 18 of the Act, a copy of every submission will be forwarded to the applicant for the applicant’s information.
The following address is:
ACVM Group, Ministry for Primary Industries, Charles Fergusson Building, 34–38 Bowen Street, Pipitea, Wellington 6011. Postal Address: PO Box 2526, Wellington 6140.
The applicant’s address for service is:
Boehringer Ingelheim Animal Health NZ Ltd, 2 Osterley Way, Manukau, Auckland 2104. Postal Address: PO Box 76211, Manukau City, Auckland 2241.
Dated at Wellington this 9th day of August 2019.
SHALEEN NARAYAN, Acting Manager Approvals Operations, Ministry for Primary Industries (acting under delegated authority).